DK1558929T3 - Kvantificering af stresseksponering - Google Patents
Kvantificering af stresseksponeringInfo
- Publication number
- DK1558929T3 DK1558929T3 DK03810513T DK03810513T DK1558929T3 DK 1558929 T3 DK1558929 T3 DK 1558929T3 DK 03810513 T DK03810513 T DK 03810513T DK 03810513 T DK03810513 T DK 03810513T DK 1558929 T3 DK1558929 T3 DK 1558929T3
- Authority
- DK
- Denmark
- Prior art keywords
- quantification
- neutrophils
- stress exposure
- exposure
- stress
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Ecology (AREA)
- Physiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Holo Graphy (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0225885.3A GB0225885D0 (en) | 2002-11-06 | 2002-11-06 | Quantifying exposure to stress |
PCT/GB2003/004749 WO2004042395A1 (en) | 2002-11-06 | 2003-11-05 | Quantifying exposure to stress |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1558929T3 true DK1558929T3 (da) | 2009-01-26 |
Family
ID=9947318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03810513T DK1558929T3 (da) | 2002-11-06 | 2003-11-05 | Kvantificering af stresseksponering |
Country Status (10)
Country | Link |
---|---|
US (1) | US7838262B2 (da) |
EP (1) | EP1558929B1 (da) |
JP (1) | JP4571864B2 (da) |
AT (1) | ATE408827T1 (da) |
AU (1) | AU2003276448A1 (da) |
DE (1) | DE60323661D1 (da) |
DK (1) | DK1558929T3 (da) |
ES (1) | ES2312854T3 (da) |
GB (1) | GB0225885D0 (da) |
WO (1) | WO2004042395A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201616640D0 (en) * | 2016-09-30 | 2016-11-16 | Sarphie David And Mian Rubina | Monitoring cancer recurrence and progression |
US20220308046A1 (en) | 2019-06-27 | 2022-09-29 | Binary Llc | Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf) |
WO2022136850A1 (en) | 2020-12-22 | 2022-06-30 | Seroxo Limited | Method for diagnosing and monitoring sepsis |
GB2619197A (en) | 2021-02-02 | 2023-11-29 | Seroxo Ltd | Monitoring COVID-19 progression and treatment |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401640A (en) * | 1992-03-30 | 1995-03-28 | Trustees Of Dartmouth College | Method for enhancing detection of superoxide anion |
US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
EP1262167A1 (de) * | 2001-06-01 | 2002-12-04 | Cognis France S.A. | Kosmetische Zubereitungen enthaltend ein Extrakt von keimenden Pflanzen |
BE1014949A3 (fr) * | 2001-08-14 | 2004-07-06 | Probiox | Procede de detection de stress oxydant et trousse pour sa mise en oeuvre. |
AU2005229008B2 (en) * | 2004-03-23 | 2011-03-24 | Lifeline Nutraceuticals Corporation | Compositions and method for alleviating inflammation and oxidative stress in a mammal |
-
2002
- 2002-11-06 GB GBGB0225885.3A patent/GB0225885D0/en not_active Ceased
-
2003
- 2003-11-05 DE DE60323661T patent/DE60323661D1/de not_active Expired - Lifetime
- 2003-11-05 AT AT03810513T patent/ATE408827T1/de active
- 2003-11-05 AU AU2003276448A patent/AU2003276448A1/en not_active Abandoned
- 2003-11-05 WO PCT/GB2003/004749 patent/WO2004042395A1/en active IP Right Grant
- 2003-11-05 DK DK03810513T patent/DK1558929T3/da active
- 2003-11-05 ES ES03810513T patent/ES2312854T3/es not_active Expired - Lifetime
- 2003-11-05 JP JP2004549334A patent/JP4571864B2/ja not_active Expired - Lifetime
- 2003-11-05 US US10/533,935 patent/US7838262B2/en not_active Expired - Lifetime
- 2003-11-05 EP EP03810513A patent/EP1558929B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60323661D1 (de) | 2008-10-30 |
US20060014235A1 (en) | 2006-01-19 |
AU2003276448A1 (en) | 2004-06-07 |
ES2312854T3 (es) | 2009-03-01 |
EP1558929A1 (en) | 2005-08-03 |
US7838262B2 (en) | 2010-11-23 |
JP4571864B2 (ja) | 2010-10-27 |
GB0225885D0 (en) | 2002-12-11 |
JP2006505263A (ja) | 2006-02-16 |
EP1558929B1 (en) | 2008-09-17 |
ATE408827T1 (de) | 2008-10-15 |
WO2004042395A1 (en) | 2004-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20041323A0 (fi) | Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi | |
EP1691192A4 (en) | METHOD FOR MEASURING A BLOOD COMPOUND, DETECTOR USED FOR THE SAME, AND MEASURING INSTRUMENT | |
DE60228557D1 (de) | Candida-nachweis | |
EP1677097A4 (en) | METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF A FLUORESCENT PIGMENT | |
AU2003228700A1 (en) | Non-invasive substance concentration measurement using an optical bridge | |
EP1939583A4 (en) | OPTICAL DEVICE, AND METHOD FOR MEASURING THE DIMENSION OF AN OBJECT USING THE OPTICAL DEVICE | |
DK2211183T3 (da) | Fremgangsmåde til diagnosticering og overvågning af Alzheimer's sygdom | |
NO339666B1 (no) | Fremgangsmåte og system for rapportering av utviklete UTRAN-egenskaper | |
EP1630562A4 (en) | DYNAMIC MATRIX SENSITIVITY MEASURING INSTRUMENT FOR INTERNAL SENSORS AND ASSOCIATED METHOD OF MEASUREMENT | |
FI20030867A (fi) | Optinen mittausmenetelmä ja laboratoriomittauslaite | |
EP1921439A4 (en) | DEVICE, INSTRUMENT AND METHOD OF MEASUREMENT | |
DK1510492T3 (da) | Fremgangsmåde til afprövning af et elevatoranlæg og elevatoranlæg | |
HK1089231A1 (en) | Light wavefront measuring instrument, light wavefront measuring method, and light source adjusting method | |
NO20081343L (no) | Biosensor-måleanordning, biosensor-målesystem og biosensor-målemetode | |
DK1630527T3 (da) | Optisk forskydningstransducer, forskydningsmålesystem og fremgangsmåde | |
WO2004081521A3 (en) | Methods for direct detection of individual methotrexate metabolites | |
DK1558929T3 (da) | Kvantificering af stresseksponering | |
WO2004113574A3 (en) | Methods for disease screening | |
MXPA04004018A (es) | Metodos de separacion por exclusion para toxicidad de compuestos de prueba. | |
DE60329360D1 (de) | Wheatstonebrücke | |
WO2007075318A3 (en) | Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof | |
TW200508936A (en) | The establishment of proteome structure profile databases and their uses | |
FI20011362A (fi) | Röntgenfluoresenssianalysaattori ja menetelmä röntgenfluoresenssianalysaattorin käyttämiseksi | |
DK1257830T3 (da) | Assay til måling af holo-transcobalamin og folat | |
ITRM20040433A1 (it) | Dispositivo ottico per la misura in linea di radiazioni elettromagnetiche. |